Jenkins, Dominick J. http://orcid.org/0000-0002-5091-2097
Woolston, Benjamin M. http://orcid.org/0000-0002-6570-2236
Hood-Pishchany, M. Indriati
Pelayo, Paula http://orcid.org/0009-0004-1508-2034
Konopaski, Alyssa N. http://orcid.org/0000-0002-3138-2342
Quinn Peters, M. http://orcid.org/0000-0001-9832-3219
France, Michael T.
Ravel, Jacques http://orcid.org/0000-0002-0851-2233
Mitchell, Caroline M. http://orcid.org/0000-0001-9924-2349
Rakoff-Nahoum, Seth http://orcid.org/0000-0002-3233-0675
Whidbey, Christopher http://orcid.org/0000-0002-2039-4284
Balskus, Emily P. http://orcid.org/0000-0001-5985-5714
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1189211, OPP1189217)
Howard Hughes Medical Institute
U.S. Department of Health and Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD000850)
Doris Duke Charitable Foundation (2019129)
National Science Foundation
Burroughs Wellcome Fund
Pew Charitable Trusts
March of Dimes Foundation
U.S. Department of Health and Human Services (1K08AI130392-01)
U.S. Department of Health and Human Services | NIH | National Institute of General Medical Sciences (DP2GM136652)
M.J. Murdock Charitable Trust (NS‐201913756)
Article History
Received: 8 July 2021
Accepted: 11 July 2023
First Online: 10 August 2023
Competing interests
: C.M.M. has served as a consultant for Scynexis Inc, Ferring Pharmaceuticals and has received research funding from Scynexis, Inc. J.R. is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutics drugs for women’s health. The other authors declare no competing interests.